Providing a model where scientists can focus on the science
Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow.
At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges.
Beyond our growing network of incubation capabilities around the world, JLABS is part of the larger Johnson & Johnson Innovation family of companies, which includes Johnson & Johnson Innovation centers, housing our deal teams and therapeutic experts for early-stage development, Johnson & Johnson Innovation – JJDC, Inc., our established venture capital arm, and Johnson & Johnson Innovation – BD, our business development group focusing on later-stage development. What that means for young companies is that, no matter what stage you’re at, we provide access to all the elements you need to develop your science and to position your company for success.